Preterm born patients with visual impairment experience reduced health-related quality of life, especially when paired with other impairments.

Intra-arterial chemotherapy for retinoblastoma can be highly successful in both treatment-naïve and non-naïve eyes.

Patients with Fuchs endothelial corneal dystrophy with particular genetic markers are at higher risk for surgery and vision loss.